All News
Filter News
Found 808,676 articles
-
United States House of Representatives Passes FASTER Act for Sesame Labeling
4/15/2021
The United States House of Representatives passed the Food Allergy Safety, Treatment, Education and Research Act, a critical piece of legislation requiring that sesame be labeled on packaged foods and prioritizing food allergy research.
-
XOMA’s Royalty Portfolio Grows with Addition of Three Royalty Assets
4/15/2021
XOMA Corporation announced its portfolio of potential future milestone and royalty assets has increased with the addition of three Affimed N.V. innate cell engager programs for which XOMA could receive future economics.
-
American Urological Association Names Next Science and Quality Chair
4/15/2021
the American Urological Association announced its Board of Directors has approved Matthew Nielsen, MD, MS, FACS, as the next chair of the AUA Science and Quality Council.
-
Embossed NPWT Dressing Successfully Completes Clinical Safety Study
4/15/2021
"Utilization of a Novel Negative Pressure Platform Wound Dressing on Surgical Incisions: A Case Series"
-
Relief Reports 2020 Financial Results and Provides Business Update
4/15/2021
RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company with its lead compound RLF-100TM in advanced clinical development to treat COVID-19 induced lung injury, announced its 2020 financial results for the year ended December 31, 2020 and provided a business update.
-
Annovis Bio Appoints Reid McCarthy to Board and to Role of Audit Committee Chairman
4/15/2021
A specialist in bank, bond, and equity financings, McCarthy retired after serving from 2016 to 2019 as CFO of JJ Haines & Company, Inc., a $400 million revenue distribution company operating internationally.
-
MustGrow Outlines Upcoming Investment Conferences
4/15/2021
MustGrow's safe and effective natural, organic biofumigant, biopesticide and bioherbicide are plant-based
-
Tryp Therapeutics to Host Investor Day on April 22
4/15/2021
Tryp would like to invite all current shareholders and prospective investors to connect directly with Tryp's management team to discuss many of the Company's achievements since its Initial Public Offering in December 2020 and look ahead to additional developments in 2021.
-
Bio-Rad to Report First-Quarter 2021 Financial Results, Thursday, April 29, 2021
4/15/2021
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the first quarter 2021 on Thursday, April 29, 2021, following the close of the market.
-
ScreenPro Security Opens its First COVID-19 Testing Walk-In Clinic in Vancouver
4/15/2021
The clinic opened in March and offers a comfortable and convenient location for ScreenPro clients.
-
Transcenta Announced Presentation of Preclinical Data of TST005 at 2021 AACR Virtual Annual Meeting
4/15/2021
Transcenta Holding Limited (Transcenta), a clinical stage global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, presented preclinical data of TST005, a bi-functional anti-PD-L1 and TGF-β trap fusion protein, in a poster during the 2021 American Association for Cancer Research (AACR) Virtual Annual Meeting
-
NeuroMetrix, Inc. Announces Date for First Quarter 2021 Financial Results Conference Call
4/15/2021
NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2021 first quarter financial results before the opening of the market on April 22, 2021. The Company will host a conference call at 8:00 a.m., Eastern Time on April 22, 2021 to discuss its financial results as well as business developments affecting the Company.
-
Cardiovascular Systems, Inc. to Webcast Fiscal 2021 Third-Quarter Earnings Conference Call Thursday, May 6
4/15/2021
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host a live webcast of its fiscal 2021 third-quarter conference call on Thursday, May 6, 2021, at 3:30 p.m. CT (4:30 p.m. ET). CSI management will discuss results for its fiscal third quarter ended March 31, 2021, and its financial outlook.
-
MJH Life Sciences™ Adds International Society for Vaccines to its Strategic Alliance Partnership
4/15/2021
MJH Life Sciences™ is proud to announce an official partnership with the International Society for Vaccines (ISV) by adding them to its Strategic Alliance Partnership (SAP) program
-
Biomerica Reports 208% Increase In Q3 Fiscal 2021 Sales, Over Q3 Fiscal 2020
4/15/2021
Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced its fiscal third quarter 2021 financial results for the three months ended February 28, 2021.
-
Helius Medical Technologies, Inc. to Present at the Planet MicroCap Showcase on April 21st
4/15/2021
Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that management will participate in the Planet MicroCap Showcase, which is being held virtually from April 20th-22nd.
-
OncoSec to Present Encore Interim Data from the KEYNOTE-695 Phase 2b Clinical Trial at the 10th World Congress of Melanoma
4/15/2021
OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a biotechnology company focused on cytokine-based intratumoral immunotherapies, today announced that it will be presenting encore interim data from its KEYNOTE-695 registration-enabled Phase 2b clinical trial evaluating TAVO™ (tavokinogene telseplasmid)
-
ContraFect Invited to Present at the Inaugural Anti-Infectives Drug Development Summit
4/15/2021
ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, today announced that Cara Cassino, MD, Chief Medical Officer and Executive Vice President of Research,
-
BioTalent Canada cements status as Canada’s voice for biotechnology HR with spot on list of Best Workplaces in Canada
4/15/2021
BioTalent Canada proudly announced today that it has been ranked #33 on the list of the 50 Best Workplaces in Canada with 10-50 employees.
-
Envista Schedules First Quarter 2021 Earnings Call
4/15/2021
Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its first quarter 2021 on Wednesday, May 5, 2021.